EpiFormer: Learning Antigen-Antibody Interactions for Epitope Prediction via Geometric Deep Learning
arXiv:2606.04154v1 Announce Type: cross Abstract: Antibodies neutralize foreign antigens by binding to specific surface regions called epitopes. Computational epitope prediction is critical for understanding immune recognition and guiding antibody engineering. However, existing methods face three fundamental challenges: antibody-aware models encode each chain independently and combine them only at a late stage, failing to capture co-dependent structural features that define binding interfaces, whereas severe class imbalance and scarcity of known antibody-antigen complexes render standard train
The proliferation of advanced AI techniques, particularly geometric deep learning, is enabling new breakthroughs in complex biological modeling that were previously intractable with traditional computational methods.
Improved epitope prediction through AI accelerates drug discovery, vaccine development, and antibody engineering, fundamentally altering the pace and cost of therapeutic innovation.
The ability to accurately predict antigen-antibody interactions at a finer structural level will de-risk early-stage R&D in immunology and infectious disease, shifting investment towards more targeted and efficient therapeutic design.
- · Biopharmaceutical companies
- · Synthetic biology researchers
- · AI/Machine Learning companies
- · Patients with infectious diseases
- · Traditional drug discovery methods
- · Companies reliant on broad-spectrum therapeutics
More efficient development of novel vaccines and antibody therapies.
A reduced timeline and cost for bringing new immunological treatments to market, increasing accessibility.
Potential for AI-driven personalized immunotherapies tailored to individual patient profiles and specific pathogen strains.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG